Alexandria, VA, United States of America

Jesse Damsker

USPTO Granted Patents = 8 

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Washington, DC (US) (2019 - 2020)
  • Alexandria, VA (US) (2022 - 2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Jesse Damsker: Innovator in Pharmaceutical Compositions

Introduction

Jesse Damsker is a prominent inventor based in Alexandria, VA, known for her contributions to the field of pharmaceutical compositions. With a total of eight patents to her name, she has made significant strides in developing innovative solutions for medical treatments.

Latest Patents

Among her latest patents is the invention of aqueous oral pharmaceutical suspension compositions, which includes vamorolone Form I. This patent not only details the composition but also outlines methods for its preparation and use. Another notable patent focuses on non-hormonal steroid modulators of NF-κβ for the treatment of various diseases, showcasing her commitment to advancing therapeutic options.

Career Highlights

Throughout her career, Jesse has worked with reputable companies such as Reveragen Biopharma, Inc. and Pioneura Corporation. Her work in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to the development of new pharmaceutical products.

Collaborations

Jesse has collaborated with notable professionals in her field, including John Michael McCall and Eric Hoffman. These partnerships have further enhanced her research and development efforts, leading to impactful advancements in pharmaceutical science.

Conclusion

Jesse Damsker's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents and collaborations reflect her dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…